467 results
Page 12 of 24
8-K
qjb1yzalghsrbv9q7
10 Aug 12
Termination of a Material Definitive Agreement
12:00am
8-K
bvwf5lax
2 Aug 12
Discovery Labs Reports Second Quarter 2012 Financial Results
12:00am
8-K
c2v8t45f6oe0yt8piq33
3 May 12
Discovery Labs Reports First Quarter 2012 Financial Results
12:00am
424B5
ga72wfb
19 Mar 12
Prospectus supplement for primary offering
12:00am
424B5
h4mwyj wmzo4tt4
15 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
y4sup
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am
424B5
3tjfr2 adfb
15 Dec 11
Prospectus supplement for primary offering
12:00am
8-K
0cbbxqram ds76hpaq
14 Dec 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
kevgom1k7zoq283np97
14 Dec 11
Entry into a Material Definitive Agreement
12:00am